Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up study of adjunctive brivaracetam in epilepsy
2012-000827-42Phase 3Completed
- Sponsor
- UCB
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brivaracetam in epilepsy, Focal Onset Epilepsy and generalized epilepsy, sponsored by UCB. Primary endpoint: Long-term safety and tolerability. Started May 2012; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset Epilepsygeneralized epilepsy
Beyond the preview
Go deeper on 2012-000827-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000827-42.